infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 46 articles from: Disease course and symptoms

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Antiviral treatment for hepatitis C virus reduces risk of post-treatment liver cancer progression

    Medical Xpress / 13 December 2021

  • Liver cancer surge as study shows Scotland has highest rates in UK

    The Herald / 07 April 2021

  • Liver Stiffness Before Hepatitis C Treatment Predicts Liver Cancer Risk

    Hep Mag / 18 January 2021

  • New tool to predict outcomes in cirrhosis of the liver

    Baylor College of Medicine / 11 November 2020

  • HCV-Related Liver Cancer Incidence Dropped in US Cohort

    Medscape / 28 September 2020

  • Racial inequalities in liver cancer deaths soared after launch of hepatitis C drugs

    Florida Atlantic University / 18 May 2020

  • Liver fibrosis associated with one type of heart failure, regardless of HIV or hepatitis C status

    News Medical Net / 25 March 2020

  • Fatty livers halt tumor-suppressing protein, increasing cancer risk

    Fierce Biotech / 21 October 2019

  • Statins Linked to Lower Risk of Liver Cancer in Patients With Hepatitis B/C

    Cancer Therapy Advisor / 23 August 2019

  • Hepatitis B Linked to Cancers Beyond the Liver

    Hep / 25 June 2019

← First12345Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • Treatment
      • HIV and HBV
      • HCV and HBV
      • Hepatitis delta
      • Living with HBV
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//